ARI vs ENTA
ARI: A REIT that originates and acquires performing commercial mortgage loans and real estate debt investments, externally managed by Apollo Global Management's real estate platform. ENTA: A biotechnology company leveraging small molecule discovery to treat viral and liver diseases, supported by recurring HCV royalty streams.
Side-by-side fundamentals
| Metric | ARI | ENTA | Edge |
|---|---|---|---|
| Price as of 2026-07-23 close | $6.76 | $12.95 | |
| Market cap as of 2026-07-24 | $885M | $380M | |
| P/E as of 2026-07-24 | 6.97 | n/a | |
| Net margin as of 2026-07-24 | +17.3% | -89.6% | ARI higher |
| Gross margin as of 2026-07-24 | +36.0% | n/a | |
| Operating margin as of 2026-07-24 | +14.8% | -87.2% | ARI higher |
| ROE as of 2026-07-24 | +6.9% | -64.0% | ARI higher |
| ROA as of 2026-07-24 | +1.3% | -20.2% | ARI higher |
| Debt / equity as of 2026-07-24 | 4.50 | 1.12 | ENTA lower |
| Revenue growth (YoY) as of 2026-07-24 | -4.8% | +7.4% | ENTA higher |
| Revenue CAGR (3y) SEC XBRL | -3.7% | -8.8% | ARI higher |
| Dividend yield as of 2026-07-24 | +14.7% | n/a | |
| Dividend streak (yrs) SEC XBRL | 1 | n/a | |
| Beta as of 2026-07-24 | 1.46 | 0.92 | |
| 1-year return as of 2026-07-23 close | -30.4% | +70.3% | ENTA higher |
Fundamentals: Finnhub, as of 2026-07-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-23.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.